Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIMJan‐Malte Placke, Selma Ugurel, Claudia Pföhler et al.|EBioMedicine|2023Cited by 49
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREGAnne Zaremba, Lisa Zimmer, Peter Mohr et al.|European Journal of Cancer|2023Cited by 13
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREGSophia Kreft, Bastian Schilling, Valerie Glutsch et al.|European Journal of Cancer|2022Cited by 12